Barclays cuts Hims & Hers price target to $35, keeps Overweight
Barclays lowers its price target on Hims & Hers Health to $35 from $39 and keeps an Overweight rating.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.